Racemose Neurocysticercosis

Abstract

Neurocysticercosis is one of the most common infections of the central nervous system in the developing world. Most often, neurocysticerci are found in the brain parenchyma, at the gray–white matter junction. A rare form of neurocysticercosis is the development of cysts at the basal subarachnoid region, termed racemose neurocysticercosis.

Keywords

neurocysticercosis - Taenia solium - treatment - meningitis - basal

• References

• 1 Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol 2011; 7 (10) 584-594
• 2 Bickerstaff ER, Cloake PC, Hughes B, Smith WT. The racemose form of cerebral cysticercosis. Brain 1952; 75 (1) 1-18
• 3 Del Brutto OH. Neurocysticercosis: a review. Continuum (Minneap Minn) 2012; 18 (6 Infectious Disease) 1392-1416
• 4 Coyle CM, Mahanty S, Zunt JR , et al. Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis 2012; 6 (5) e1500
• 5 Del Brutto OH, García HH. Neurocysticercosis in nonendemic countries: time for a reappraisal. Neuroepidemiology 2012; 39 (2) 145-146
• 6 Garcia HH, Del Brutto OH. Cysticercosis Working Group in Peru. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005; 4 (10) 653-661
• 7 White Jr AC, Robinson P, Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol 1997; 66: 209-230
• 8 Mishra BB, Mishra PK, Teale JM. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J Neuroimmunol 2006; 181 (1-2) 46-56
• 9 Verma A, Prasad KN, Cheekatla SS, Nyati KK, Paliwal VK, Gupta RK. Immune response in symptomatic and asymptomatic neurocysticercosis. Med Microbiol Immunol (Berl) 2011; 200 (4) 255-261
• 10 Sáenz B, Fleury A, Chavarría A , et al. Neurocysticercosis: local and systemic immune-inflammatory features related to severity. Med Microbiol Immunol (Berl) 2012; 201 (1) 73-80
• 11 Del Brutto OH, Del Brutto VJ. Changing pattern of neurocysticercosis in an urban endemic center (Guayaquil, Ecuador). J Neurol Sci 2012; 315 (1–2) 64-66
• 12 Sorvillo FJ, DeGiorgio C, Waterman SH. Deaths from cysticercosis, United States. Emerg Infect Dis 2007; 13 (2) 230-235
• 13 Croker C, Redelings M, Reporter R, Sorvillo F, Mascola L, Wilkins P. The impact of neurocysticercosis in California: a review of hospitalized cases. PLoS Negl Trop Dis 2012; 6 (1) e1480
• 14 O'Neal S, Noh J, Wilkins P , et al. Taenia solium tapeworm infection, Oregon, 2006-2009. Emerg Infect Dis 2011; 17 (6) 1030-1036
• 15 Carabin H, Ndimubanzi PC, Budke CM , et al. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 2011; 5 (5) e1152
• 16 Nicoletti A, Bartoloni A, Sofia V , et al. Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey. Epilepsia 2005; 46 (7) 1127-1132
• 17 Rajshekhar V, Raghava MV, Prabhakaran V, Oommen A, Muliyil J. Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology 2006; 67 (12) 2135-2139
• 18 Del Brutto OH, Rajshekhar V, White Jr AC , et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001; 57 (2) 177-183
• 19 Mont'Alverne Filho FE, Machado LdosR, Lucato LT, Leite CC. The role of 3D volumetric MR sequences in diagnosing intraventricular neurocysticercosis: preliminar results. Arq Neuropsiquiatr 2011; 69 (1) 74-78
• 20 Bandres JC, White Jr AC, Samo T, Murphy EC, Harris RL. Extraparenchymal neurocysticercosis: report of five cases and review of management. Clin Infect Dis 1992; 15 (5) 799-811
• 21 Proaño JV, Madrazo I, Avelar F, López-Félix B, Díaz G, Grijalva I. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 2001; 345 (12) 879-885
• 22 Angeles CF, Vollmer D, Mohanty A. Transventricular neuroendoscopic excision of giant racemose subarachnoid cysticercosis. Childs Nerv Syst 2009; Apr; 25 (4) 503-508
• 23 Callacondo D, Garcia HH, Gonzales I, Escalante D, Nash TE. Cysticercosis Working Group in Peru. High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis. Neurology 2012; 78 (18) 1394-1400
• 24 Flisser A, Plancarte A, Correa D , et al. New approaches in the diagnosis of Taenia solium cysticercosis and taeniasis. Ann Parasitol Hum Comp 1990; 65 (Suppl. 01) 95-98
• 25 Singh G, Rajshekhar V, Murthy JM , et al. A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology 2010; 75 (24) 2236-2245
• 26 Garcia HH, Gonzalez AE, Gilman RH. Cysticercosis of the central nervous system: how should it be managed?. Curr Opin Infect Dis 2011; 24 (5) 423-427
• 27 Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006; 145 (1) 43-51
• 28 Nash TE, Singh G, White AC , et al. Treatment of neurocysticercosis: current status and future research needs. Neurology 2006; 67 (7) 1120-1127
• 29 Couldwell WT, Zee CS, Apuzzo ML. Definition of the role of contemporary surgical management in cisternal and parenchymatous cysticercosis cerebri. Neurosurgery 1991; 28 (2) 231-237
• 30 Del Brutto OH. Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients. J Neurol Neurosurg Psychiatry 1997; 62 (6) 659-661
• 31 Garcia HH, Rodriguez S, Gilman RH, Gonzalez AE, Tsang VC. Cysticercosis Working Group in Peru. Neurocysticercosis: is serology useful in the absence of brain imaging?. Trop Med Int Health 2012; 17 (8) 1014-1018
• 32 Angeles CF, Vollmer D, Mohanty A. Transventricular neuroendoscopic excision of giant racemose subarachnoid cysticercosis. Childs Nerv Syst 2009; 25 (4) 503-508